Erratum: Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice (Molecular Neurodegeneration (2013) 8:26)

Katherine D. Laclair, Kebreten F. Manaye, Dexter L. Lee, Joanne S. Allard, Alena V. Savonenko, Juan C. Troncoso, Philip C. Wong

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Article number26
JournalMolecular neurodegeneration
Issue number1
StatePublished - 2013

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this